<

EVOTEC AG (NASDAQ:EVTCY) Evotec and Bristol Myers Squibb extend and expand strategic partnership

Transparency directive : regulatory news

10/05/2022 16:29

DGAP-Ad-hoc: Evotec SE / Key word(s): Miscellaneous
Evotec and Bristol Myers Squibb extend and expand strategic partnership

10-May-2022 / 16:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces today that the Company has extended and expanded its partnership with Bristol Myers Squibb (NYSE:BMY) in targeted protein degradation, originally signed in 2018.

Aim of the eight-year extension is to develop a broad pipeline of molecular glue degraders which are small, drug-like compounds. Bristol Myers Squibb is a leader in this field in particular based on its unique library CELMoD®.

Under the terms of the agreement, Evotec’s proprietary EVOpanOmics and EVOpanHunter platforms as well as AI/ML-based drug discovery and development platforms will be leveraged.

Evotec receives an upfront payment of $ 200 m and expects to obtain further performance-based, near-term and programme-based milestone payments, resulting in a deal potential of $ 5 bn with additional tiered royalties on product sales.

– End of ad hoc release –

Contact: Dr Werner Lanthaler, Chief Executive Officer, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49.(0)40.560 81-242, werner.lanthaler@evotec.com


10-May-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Phone: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222
E-mail: info@evotec.com
Internet: www.evotec.com
ISIN: DE0005664809
WKN: 566480
Indices: MDAX, TecDAX
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq
EQS News ID: 1348655

 
End of Announcement DGAP News Service

1348655  10-May-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1348655&application_name=news&site_id=symex


Other stories

29/03/2024 09:33
29/03/2024 06:51
29/03/2024 01:37
29/03/2024 07:00
29/03/2024 08:43
29/03/2024 03:31
29/03/2024 09:19
28/03/2024 16:29
29/03/2024 03:31
28/03/2024 18:06
29/03/2024 05:39
29/03/2024 07:00
28/03/2024 21:00
28/03/2024 22:24
29/03/2024 09:14
29/03/2024 05:12
29/03/2024 00:37
29/03/2024 06:02
27/03/2024 15:52
27/03/2024 19:23
28/03/2024 12:03
27/03/2024 22:02
29/03/2024 03:19
28/03/2024 19:05
29/03/2024 03:31
29/03/2024 01:27
29/03/2024 00:29
28/03/2024 23:33
29/03/2024 04:12
29/03/2024 07:21
29/03/2024 01:26
27/03/2024 21:46
28/03/2024 17:55
28/03/2024 12:18
28/03/2024 13:25
29/03/2024 00:01
28/03/2024 12:57
28/03/2024 10:00